Showing posts with label Healthcare Contract Manufacturing Market demand. Show all posts
Showing posts with label Healthcare Contract Manufacturing Market demand. Show all posts

Sunday, 13 December 2020

Healthcare Contract Manufacturing Market- Global Analysis, Regional Trends and Forecast till 2023

 Market Scenario

The global healthcare contract manufacturing market is presumed to expand at 9.86 % CAGR during the forecast period (2017-2023) owing to the growing demand for medicine supplies, asserts Market Research Future (MRFR). Healthcare contract manufacturing is the outsourcing of the manufacturing process of drugs to contract manufacturing organizations. It serves other companies in pharmaceutical industries and medical devices to offer comprehensive services from drug development to drug manufacturing.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5637 

Drivers and Constraints Impacting the Market

Patent protection expiration of major drugs along with medical devices and competition and economics of trade and production to favor CMO is likely to foster the market growth during the assessment period. The market is likely to expand owing to the growing demand for medical devices and drugs due to the increasing population in the emerging economies. Moreover, with the increasing demand for generic drugs, the rising number of patent expiries, and huge pipeline of drugs, the global market for healthcare contract manufacturing is anticipated to augment in the coming years.

On the flip side, issues of control of third parties coupled with complexities associated with supply chain are considered to retard the market growth over the assessment period. Also, rising complexities in the clinical trials along with lack of in-house laboratory capacity are likely to impede the growth of the market.

Global Healthcare Contract Manufacturing Market: Segmental Analysis

The global healthcare CMO market has been segmented on the basis of service type, type, industry, and region.

By mode of type, the global healthcare contract manufacturing market has been segmented into non-sterile and sterile. Among these, the non-sterile contract manufacturing is estimated to hold the largest market share.

By mode of service type, the global healthcare contract manufacturing market has been segmented into medical device contract manufacturing services and pharmaceutical contract manufacturing services. Among these, the pharmaceutical contract manufacturing services are presumed to hold the largest market share.

By mode of industry, the global healthcare contract manufacturing market has been segmented into biopharmaceutical, medical device, and pharmaceutical. Among these, the segment for medical devices is presumed to hold the largest market share with 43.7 %.

Regional Insights

Geographically, the global healthcare contract manufacturing market span across America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, the American region is anticipated to dominate the global market due to the growing investment in the healthcare sector, focus on research institutions on updating technologies, and presence of strong economic conditions. American contract manufacturers have also upgraded their factories and manufacturing capabilities. With cost-efficient models and advanced manufacturing units, American contract manufacturers are making Asian companies run for their money.

The European region is considered to hold the second position in the global market owing to the presence of high health care spending, and growing support from the government. For instance, according to the Organization for Economic Co-operation and Development, the expenditure on healthcare in Germany in 2014 was EUR 321 billion. France recorded the second highest level with EUR 237 billion.

Asia Pacific is presumed to be the fastest growing market due to the presence of a large number of developing nations in this region, such as China and India. Such developing countries are encouraging the growth of healthcare contract manufacturing market.

Industry News

October 16, 2018: Piramal Enterprises Ltd. is weighing the sale of its contract pharmaceutical business in a potential deal worth $1 billion, citing unidentified people. Piramal Pharma Solutions offer services from drug discovery to development as well as commercial manufacturing, with operations in Europe, North America, and Asia. The company has sent out preliminary marketing materials to potential buyers.

Competitive Dashboard

The major players operating the global market are Boehringer Ingelheim, Benchmark Electronics, Catalant, Patheon, Vetter Pharma International, Hamilton Company, Aesica Pharmaceuticals, AbbVie, Grifols International, Flex Ltd, Lonza Ag, Forefront Medical Technologies, Sanmina Corporation, Evonik Industries, Mylan, S.A, Teva Pharmaceutical Industries, and others.


Read More @ https://www.marketresearchfuture.com/reports/healthcare-contract-manufacturing-market-5637 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com


Wednesday, 8 April 2020

Update: Healthcare Contract Manufacturing Market booming with highest CAGR Value 9.8% by 2023

Overview:
The healthcare contract manufacturing market is benefiting much from the growing demand for medicine supplies which is facing a severe crisis from the pending expiration of a lot of generic drugs. The market relies heavily on the outsourcing of the manufacturing process of drugs to contract manufacturers. From drug development to drug manufacturing, a comprehensive platform this healthcare contract manufacturing sector provides. The from drug development to drug manufacturing market is expecting a growth by 9.86% during the forecast period (2017-2023), claims Market Research Future (MRFR). The report ensures a detailed analysis of the segments and driving factors that can assist the market in growth over the review period. 
Among the factors, patent expiration of several drugs can be deemed as one of the chief influencers that can foster the market growth during the forecast period. Emerging economies are demanding for greater percolation as the population boom in those countries have created scope for substantial market expansion. Drug manufacturers are also looking for significant contribution from these companies as number of drugs in the pipeline is getting piled up. Factors such as these are bound to boost the global from drug development to drug manufacturing market.
On the flip side, controlling third parties is quite complex which many manufacturers prefer to avoid. At the same time, clinical trials are becoming more exhaustive and tangled which can deter the healthcare contract manufacturing market from having the expected growth rate over the review period.
Segmentation:
The global healthcare contract manufacturing market can be segmented by type, service type, and industry.
Based on the type, the healthcare contract manufacturing market can be segmented into sterile and non-sterile.
On the basis of the service type, the healthcare contract manufacturing market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.
Industry-wise segmentation of the healthcare contract manufacturing market includes pharmaceutical, medical device, and biopharmaceutical.
Regional Analysis:
Region-specific analysis of the global healthcare contract manufacturing market includes the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas is in charge of the global healthcare contract manufacturing market. With rising investment in healthcare, the focus is mainly on improving healthcare infrastructure and upgrading research institutions for better technology and others. Subsequently, manufacturers are now relying more on the advanced instruments they have put in use in their factories and manufacturing capabilities. 
Europe assumes the second position in the market and the credit goes to the increased expenditure initiated by the regional governments. The reports published by the Organization for Economic Co-operation and Development (OECD) discloses that Germany spent USD 321 billion in 2014 in the healthcare sector which is a significant marker of the progress the regional market is making at present. 
The APAC is the fastest growing market as major regional economies such as China and India are considerably investing to better their healthcare facilities to lure in patients from all over the world as a part of their medical tourism planning.
Competitive Analysis:
Some of the key players in this healthcare contract manufacturing market are Aesica Pharmaceuticals, Boehringer Ingelheim, AbbVie, Grifols International, S.A, Evonik Industries, Lonza Ag, Catalent, Benchmark Electronics, Flex Ltd, Forefront Medical Technologies, Hamilton Company, Sanmina Corporation, Teva Pharmaceutical Industries, Patheon, Mylan, Vetter Pharma International, and others.
In August 2018, Catalent completed their move to acquire Juniper. This would give the former a new and robust European base to function. Catalent, as the parent company of Juniper, would ensure the supply of Crinone marketed by Merck KGaA. 
In January 2018, Intermountain Healthcare declared their plan to create a non-profit generic drug company as a direct manufacturer or contract manufacturer in collaboration with Ascension, SSM Health, and Trinity Health. 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.